Dr Pippa Corrie
/content/dam/asset-migration/headshots/uk-doctor-headshots/UK_Oncology_Headshot_GA_Dr Pippa Corrie.jpg

Dr Pippa Corrie

Dr Pippa Corrie
Pippa
Corrie
PhD, FRCP, Medical Oncologist

Languages spoken

English

Expert in

Pancreatic cancer, biliary cancer, liver cancer, neuroendocrine tumours and melanoma.

Overview

Centres

Cambridge
Cambridge

Fordham Rd, Newmarket CB8 7XN

52.26243294702835, 0.3985662288360208
/uk/our-centres/cambridge
+44 (0)1223 907600
mediahawkNumber3676 mhMobile

Specialises in

Skin cancer
Condition
Condition/Cancer
Condition/Cancer/Skin cancer
Gastrointestinal cancer
Condition
Condition/Cancer
Condition/Cancer/Gastrointestinal cancer

Treatments

Chemotherapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Chemotherapy
Immunotherapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Immunotherapy
Targeted therapy
Service
Service/Cancer
Service/Cancer/Medical oncology
Service/Cancer/Medical oncology/Targeted therapy
Radiotherapy
Service
Service/Cancer
Service/Cancer/Radiotherapy

Special clinical interests in pancreatic cancer, biliary cancer, liver cancer, neuroendocrine tumours and melanoma.

Dr Corrie qualified in medicine at Oxford University, having already undertaken a PhD in anti-cancer drug development. She undertook specialist training in Medical Oncology in Birmingham before being appointed as Consultant at Cambridge University Hospitals NHS Foundation Trust (Addenbrooke’s Hospital) in 1996 and subsequently Associate Lecturer at the University of Cambridge.

She has been closely involved in developing modern therapeutics for melanoma and pancreaticobiliary cancers. Dr Corrie holds national roles in the National Institute of Health Research and National Cancer Research Institute. She is the chief investigator of multiple academic and industry-sponsored national and international clinical trials. She has published widely in high impact journals. 

Career positions

Current position(s)

  • Consultant and Associate Lecturer in Medical Oncology, Addenbrooke’s Hospital Cambridge, and the University of Cambridge

Year qualified

  • 1989

Expertise and interests

Interests

  • Melanoma evolution and treatment
  • Pancreaticobiliary cáncer systemic therapies
  • Experimental therapeutics
  • Immunotherapy biomarkers of response and toxicity

Professional association

  • Fellow of the Royal College of Physicians (FRCP)
  • Member of the British Association for Cancer Research
  • Member of the American Society of Clinical Oncology
  • Member of the European Organisation for Research and Treatment of Cancer – Melanoma and Gastro-intestinal Cancer Groups
  • Member of the Medical Defence Union
  • Chair, National Cancer Research Institute Pancreatic Workstream
  • Melanoma Focus Charity Trustee